Skip to main content
Log in

Structure–activity relationship in a series of natural and synthetic inhibitors of 5-lipoxygenase catalytic activity

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Structural features characteristic of high-, medium-, and low-efficiency inhibitors of 5-lipoxygenase (5-LOG) catalytic activity were established. The degree of their influence on the inhibition efficiency was assessed. Two models (M1 and M2) were constructed for the prediction and recognition of the efficiency intervals of 5-LOG inhibitors. The confidence level of activity prediction for M1 and M2 reached 90 and 70%, respectively. The revealed structural features could be used for constructing highly selective inhibitors of 5-LOG catalytic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. J. C. Boyington, B. J. Gaffney, and L. M. Amzel, Pharmacology, 38, 199–205 (1985).

    Google Scholar 

  2. E. Pontiki and D. Hadjipavlou-Litina, Curr. Enzyme Inhib., 1, 309–327 (2005).

    Article  Google Scholar 

  3. E. C. Webb, Enzyme Nomenclature, Academic Press, San Diego (1992).

    Google Scholar 

  4. G. D. Jones, L. Russell, V. M. Darley-Usmar, D. Stone, and M. T. Wilson, Biochemistry, 35, 7197–7203 (1996).

    Article  PubMed  CAS  Google Scholar 

  5. H. Tapiero, D. Townsend, and K. Tew, Biomed. Pharmacother., 58, 183–193 (2004).

    Article  PubMed  CAS  Google Scholar 

  6. L. A. Tyurina, O. V. Tyurina, and A. M. Kolbin, Methods and Results of the Design and Prediction of Biologically Active Compounds [in Russian], Gilem, Ufa (2007).

  7. E. Block, R. Iyer, S. Grisoni, et al., J. Am. Chem. Soc., 110, 7813–7827 (1988).

    Article  CAS  Google Scholar 

  8. S. T. Prigge, J. S. Boyington, M. Faig, and K. S. Doctor, Biochimie, 79, 629–636 (1997).

    Article  PubMed  CAS  Google Scholar 

  9. Y. Vasques-Martinez, R. V. Ohri, V. Kenyon, and T. R. Holman, Bioorg. Med. Chem., 15, 7408–7425 (2007).

    Article  Google Scholar 

  10. A. B. Camargo and E. Marchevsky, J. Agric. Food Chem., 55, 3096–3103 (2007).

    Article  PubMed  CAS  Google Scholar 

  11. D. S. Weinstein, W. Liu, K. Ngu, et al., Bioorg. Med. Chem. Lett., 17, 5115–5120 (2007).

    Article  PubMed  CAS  Google Scholar 

  12. P. N. P. Rao, Q.-H. Chen, and E. E. Knaus, J. Med. Chem., 49, 1668–1683 (2006).

    Article  PubMed  CAS  Google Scholar 

  13. U. P. Singh, B. Prithiviraj, B. K. Sarma, et al., Indian J. Exp. Biol., 39, 310–322 (2001).

    PubMed  CAS  Google Scholar 

  14. U. P. Kelavkar,W. Glasgow, S. J. Olson, and B. A. Foster, Neoplasia, 6, 821–830 (2004).

    PubMed  CAS  Google Scholar 

  15. R. J. Hsieh, J. B. German, and J. E. Kinsella, Lipids, 23, 322–326 (1988).

    Article  PubMed  CAS  Google Scholar 

  16. O. Werz, B. Szellas, and D. Steinhilber, Eur. J. Biochem., 267, 1263–1269 (2000).

    Article  PubMed  CAS  Google Scholar 

  17. E. T. Denisov and I. B. Afanas?ev, Oxidation and Antioxidants in Organic Chemistry and Biology, Talyor & Francis, Boca Raton (2005).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Ya. Gerchikov.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 46, No. 9, pp. 33 – 43, September, 2012.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khairullina, V.R., Taipov, I.A., Gerchikov, A.Y. et al. Structure–activity relationship in a series of natural and synthetic inhibitors of 5-lipoxygenase catalytic activity. Pharm Chem J 46, 553–564 (2012). https://doi.org/10.1007/s11094-012-0846-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-012-0846-5

Key words

Navigation